CD40 C/T-1 polymorphism plays different roles in Graves' disease and Hashimoto's thyroiditis: A meta-analysis

Endocrine Journal

Volumn 59, Issue 12, 2012, Pages 1041-1050

  Li, Ming ^a   Sun, Haiming ^a   Liu, Shoujun ^a   Yu, Jun ^a   Li, Qiang ^b   Liu, Peng ^a   Shen, Hongmei ^a   Sun, Dianjun ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Autoimmune thyroid diseases; CD40; Meta analysis; Polymorphism

Indexed keywords

CD40 ANTIGEN;

ARTICLE; ASIAN; CAUCASIAN; DISEASE PREDISPOSITION; ETHNICITY; EUTHYROIDISM; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; RISK ASSESSMENT;

ANTIGENS, CD40; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVIEW LITERATURE AS TOPIC;

EID: 84872095056     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0126     Document Type: Article

References (57)

1. Szyper-Kravitz M, Marai I, Shoenfeld Y (2005) Coexistence of thyroid autoimmunity with other autoimmune diseases: friend or foe? Additional aspects on the mosaic of autoimmunity. Autoimmunity 38: 247-255.
2. Wang C, Crapo LM (1997) The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 26: 189-218.
3. Ueda H, Howson JM, Esposito L, Heward J, Snook H, et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511.
4. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, et al. (1994) The CD40 antigen and its ligand. Annu Rev Immunol 12: 881-922.
5. Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC (1993) Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol 150: 3671-3680.
6. Arpin C, Dechanet J, Van Kooten C, Merville P, Grouard G, et al. (1995) Generation of memory B cells and plasma cells in vitro. Science 268: 720-722.
7. Metcalfe RA, McIntosh RS, Marelli-Berg F, Lombardi G, Lechler R, et al. (1998) Detection of CD40 on human thyroid follicular cells: analysis of expression and function. J Clin Endocrinol Metab 83: 1268-1274.
8. Smith TJ, Sciaky D, Phipps RP, Jennings TA (1999) CD40 expression in human thyroid tissue: evidence for involvement of multiple cell types in autoimmune and neoplastic diseases. Thyroid 9: 749-755.
9. Smith TJ, Sempowski GD, Berenson CS, Cao HJ, Wang HS, et al. (1997) Human thyroid fibroblasts exhibit a distinctive phenotype in culture: characteristic ganglioside profile and functional CD40 expression. Endocrinology 138: 5576-5588.
10. Faure GC, Bensoussan-Lejzerowicz D, Bene MC, Aubert V, Leclere J (1997) Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells. Clin Immunol Immunopathol 84: 212-215.
11. Carayanniotis G, Masters SR, Noelle RJ (1997) Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunology 90: 421-426.
12. Peterson KE, Braley-Mullen H (1999) CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous experimental autoimmune thyroiditis. J Autoimmun 12: 1-12.
13. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF (1998) A new Graves disease-susceptibility locus maps to chromosome 20q11.2. International Consortium for the Genetics of Autoimmune Thyroid Disease. Am J Hum Genet 63: 1749-1756.
14. Tomer Y, Concepcion E, Greenberg DA (2002) A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12: 1129-1135.
15. Jacobson EM, Concepcion E, Oashi T, Tomer Y (2005) A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146: 2684-2691.
16. Park JH, Chang HS, Park CS, Jang AS, Park BL, et al. (2007) Association analysis of CD40 polymorphisms with asthma and the level of serum total IgE. Am J Respir Crit Care Med 175: 775-782.
17. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
18. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
19. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
20. Munafo MR, Clark TG, Flint J (2004) Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Psychiatry Res 129: 39-44.
21. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
22. Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455-463.
23. Ban Y, Tozaki T, Taniyama M, Tomita M (2006) Association of a C/T single-nucleotide polymorphism in the 5' untranslated region of the CD40 gene with Graves' disease in Japanese. Thyroid 16: 443-446.
24. Heward JM, Simmonds MJ, Carr-Smith J, Foxall H, Franklyn JA, et al. (2004) A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians. Clin Endocrinol (Oxf) 61: 269-272.
25. Houston FA, Wilson V, Jennings CE, Owen CJ, Donaldson P, et al. (2004) Role of the CD40 locus in Graves' disease. Thyroid 14: 506-509.
26. Hsiao JY, Tien KJ, Hsiao CT, Hsieh MC (2008) A C/T polymorphism in CD40 gene is not associated with susceptibility and phenotype of Graves' disease in Taiwanese. Endocr J 55: 477-484.
27. Jacobson EM, Huber AK, Akeno N, Sivak M, Li CW, et al. (2007) A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun 8: 205-214.
28. Kim TY, Park YJ, Hwang JK, Song JY, Park KS, et al. (2003) A C/T polymorphism in the 5'-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid 13: 919-925.
29. Kurylowicz A, Kula D, Ploski R, Skorka A, Jurecka-Lubieniecka B, et al. (2005) Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease. Thyroid 15: 1119-1124.
30. Makni K, Hadj Kacem H, Rebai A, Abid M, Ayadi H (2007) Association and linkage studies of the 20q11.2 region (GRD-2 locus) with Graves' disease in the Tunisian population. Ann Hum Biol 34:566-572.
31. Meng FT, Sun HM, Qiao YD, Li Q, Chen F, et al. (2006) Study on the association of a C/T single nucleotide polymorphism in the kozak of the CD40 gene with Graves Disease. Int J Genet 29: 16-18 (In Chinese).
32. Mukai T, Hiromatsu Y, Fukutani T, Ichimura M, Kaku H, et al. (2005) A C/T polymorphism in the 5' untranslated region of the CD40 gene is associated with later onset of Graves' disease in Japanese. Endocr J 52: 471-477.
33. Sun LL, Zhu X, Huang W, Bi FY (2007) Study on the association of CD40 polymorphism with Graves Disease. J Pract Med 23:655-657 (In Chinese).
34. Sun YM, Xiao ZH, Huang P, Fu MJ, Zhou Z (2009) Correlation between CD40 gene polymorphism and Graves' disease in Guangdong Han population of south China. Guangdong Med J 30: 60-62 (In Chinese).
35. Yang J, Qin Q, Yan N, Zhu YF, Li C, et al. (2012) CD40 C/T(-1) and CTLA-4 A/G(49) SNPs are associated with autoimmune thyroid diseases in the Chinese population. Endocrine 41: 111-115
36. Zhang Y, Zhu BZ, Sun Y (2008) Association of CD40 gene 5' UTR C(-1)T,-58038T and C64610G polymorphism with autoimmune thyroid disorders. J Xi'an Jiaotong Univ (Med Sci) 29: 294-304 (In Chinese).
37. Kim KW, Park YJ, Kim TY, Park do J, Park KS, et al. (2007) Susceptible alleles of the CD40 and CTLA-4 genes are not associated with the relapse after antithyroid withdrawal in Graves' disease. Thyroid 17: 1229-1234.
38. Luo HX, Zhang P, Gao ZH, Qiu MC (2006) Association between Hepatic Injury of Graves' Disease and a C/T Single-Nucleotide Polymorphism of the CD40 Gene. Tianjin Med J 34: 525-526 (In Chinese).
39. Ma LD, Yan SL, Li P, Wang L, Qi YQ (2010) The relationship between CD40 gene 5′ untranslated region position 1 site C/T polymorphism and the relapse of Grave's disease after antithyroid withdrawal. Immunol J 26: 517-526 (In Chinese).
40. Pichurin P, Pham N, David CS, Rapoport B, McLachlan SM (2006) HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism. Thyroid 16: 1221-1227.
41. Ajjan RA, Weetman AP (2004) New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy. J Endocrinol Invest 27: 237-245.
42. Dittmar M, Kahaly GJ (2005) Immunoregulatory and susceptibility genes in thyroid and polyglandular autoimmunity. Thyroid 15: 239-250.
43. Jacobson EM, Tomer Y (2007) The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 28: 85-98.
44. Luo HX, Gao ZH (2006) CD40 gene polymorphism and Graves' disease. Occup Health 15: 1153-1155 (In Chinese).
45. Peters AL, Stunz LL, Bishop GA (2009) CD40 and autoimmunity: the dark side of a great activator. Semin Immunol 21: 293-300.
46. Simmonds MJ, Heward JM, Franklyn JA, Gough SC (2005) The CD40 Kozak SNP: a new susceptibility loci for Graves' disease? Clin Endocrinol (Oxf) 63: 232-233.
47. Sun, LL, Wang Y, Huang W (2006) The Studies on the Polymorphisms of Candidate Genes Responsible for the Graves' Disease. Int J Genet 29: 62-65 (In Chinese).
48. Tomer Y (2010) Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid 20: 715-725.
49. Tomer Y, Davies TF, Greenberg DA (2005) What is the contribution of a Kozak SNP in the CD40 gene to Graves' disease? Clin Endocrinol (Oxf) 62: 258.
50. Zhang Y, Sun Y, Zhu BZ (2005) CD40/CD40L molecules and autoimmune thyroid disease and diabetes. Foreign Med Sci Endocr 25: 99-101 (In Chinese).
51. Hsiao JY, Hsieh MC, Hsiao CT, Weng HH, Ke DS (2008) Association of CD40 and thyroglobulin genes with later-onset Graves' disease in Taiwanese patients. Eur J Endocrinol 159: 617-621.
52. Luo HX, Zhang P, Qiu MC (2006) The Association between Graves' Disease and a C/T Single-Nucleotide Polymorphism in the CD40 Gene. Tianjin Med J 34: 229-230 (In Chinese).
53. Mysliwiec J, Oklota M, Nikolajuk A, Waligorski D, Gorska M (2007) Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response. Immunol Invest 36: 247-257.
54. Buck D, Kroner A, Rieckmann P, Maurer M, Wiendl H (2006) Analysis of the C/T(-1) single nucleotide polymorphism in the CD40 gene in multiple sclerosis. Tissue Antigens 68: 335-338.
55. Blanco-Kelly F, Matesanz F, Alcina A, Teruel M, Diaz-Gallo LM, et al. (2010) CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility. PLoS One 5: e11520.
56. Melanie Bahlo (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 41: 824-828.
57. Zheng J, Liu Y, Qin G, Chan PL, Mao H, et al. (2009) Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells. J Immunol 183: 3742-3750.